Thalamus's Ventral Posterolateral Nucleus

Description

Ventral posterolateral (VPL) nucleus occupies the posterolateral portion of the thalamic lateral mass, positioned anterior to the pulvinar on the superior aspect of the diencephalon. From a superior viewpoint, the VPL sits lateral to the midline and third ventricular region, with its lateral margin approaching the internal capsule, a relationship that helps explain how small vascular lesions can combine sensory and motor findings. Posteriorly the pulvinar forms a broader cap over the thalamic tail, while the VPL lies just forward of that posterior prominence within the ventral posterior nuclear territory. Borders matter here. Functionally, the VPL is the principal thalamic relay for somatosensory input from the contralateral body, receiving ascending fibers from the medial lemniscus (discriminative touch and proprioception) and spinothalamic tract (pain and temperature) before projecting to primary somatosensory cortex in the postcentral gyrus. Infarcts in the posterior cerebral artery perforators (classically thalamogeniculate branches) or small hemorrhages involving the posterolateral thalamus can produce contralateral hemisensory loss, and some patients develop central post-stroke pain (Dejerine-Roussy syndrome) after injury in this region. The fixed superior perspective also helps differentiate VPL from the ventral posteromedial nucleus (VPM), which lies more medial and relates to facial sensation, a distinction that is easy to blur in less anatomically disciplined schematics. Use this illustration in neuroanatomy and neuroscience teaching modules on the dorsal column medial lemniscus pathway, the anterolateral system, and thalamocortical topography, or in neurology and neuroradiology publications discussing pure sensory stroke and thalamic pain syndromes. It also fits surgical and pain-medicine references when orienting readers to deep targets and adjacent internal capsule risk zones during stereotactic planning. Anatomical accuracy verified by SciePro's Medical Advisory Board.